COURTNEY MORALES: Open Payments
NPI 1386488807 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 26 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $80 |
| Lilly USA, LLC | 4 | $78 |
| Lundbeck LLC | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Exact Sciences Corporation | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| PFIZER INC. | 1 | $26 |
Products named: Korlym, MOUNJARO, REXULTI, The Cologuard Plus Collection Kit, JARDIANCE, GEMTESA, Kerendia, SHINGRIX.
Industry payments across TX — which companies pay providers there.
